Market Place
Sourcing Support
Longeveron Names Jerome Bailey Vice President of Business Operations
15 Sep 2022 //
GLOBENEWSWIRE
Regeneron Completes Acquisition of Checkmate Pharmaceuticals
31 May 2022 //
PRNEWSWIRE
Checkmate details troubled future if Regeneron deal fails
14 May 2022 //
FIERCEBIOTECH
Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
A promising cancer drug leads Regeneron to reconsider its aversion to M&A
20 Apr 2022 //
BIOPHARMADIVE
Checkmate Pharma Presents Trial Biomarker Data with Vidutolimod at AACR
08 Apr 2022 //
GLOBENEWSWIRE
Checkmate Pharma Announces Full Year 2021 Financial Results
30 Mar 2022 //
GLOBENEWSWIRE
Checkmate Pharma to Present at the 2022 AACR
08 Mar 2022 //
GLOBENEWSWIRE
Checkmate plucks BMS exec Bash to be new CEO
10 Feb 2022 //
FIERCEBIOTECH
Checkmate Pharma Welcomes Jon Wigginton to its Board of Directors
31 Jan 2022 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals Strengthens Board of Directors with Appointment
20 Dec 2021 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Ph2
20 Dec 2021 //
GLOBENEWSWIRE
Checkmate Presents Data for Phase 1b Study Evaluating Vidutolimod at SITC
12 Nov 2021 //
GLOBENEWSWIRE
Checkmate Announces Q3 2021 Financial Results and Provides Business Update
12 Nov 2021 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals Announces Final Data Presentation for Phase 1b
01 Nov 2021 //
GLOBENEWSWIRE
Checkmate CEO exits one-asset biotech, board member fills post
28 Oct 2021 //
FIERCEBIOTECH
Checkmate Pharmaceuticals Announces CEO Transition
27 Oct 2021 //
GLOBENEWSWIRE
Checkmate Announces Webcast on CMP-001
20 Oct 2021 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare
14 Sep 2021 //
GLOBENEWSWIRE
Checkmate Pharma to Present at the BTIG Virtual Biotechnology Conference
02 Aug 2021 //
BUSINESS WIRE
Checkmate Announces Clinical Supply Agreement with Regeneron
10 May 2021 //
GLOBENEWSWIRE
Checkmate Announces Initiation of Patient Dosing in Vidutolimod trial
04 May 2021 //
PIPELINE REVIEW
Checkmate Announces Initiation of Patient Dosing in Phase 2
19 Apr 2021 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals to Present Data at the 2021 AACR
10 Mar 2021 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team
04 Jan 2021 //
GLOBENEWSWIRE
Checkmate Announces Clinical Collaboration with Bristol Myers Squibb
08 Dec 2020 //
GLOBENEWSWIRE
Checkmate Pharmaceuticals Presents Updated Clinical Data with CMP-001
09 Nov 2020 //
GLOBENEWSWIRE
Checkmate Announces Data Presentations for CMP-001 at The Society f
15 Oct 2020 //
GLOBENEWSWIRE
CheckMate -649, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Chemotherapy
10 Aug 2020 //
BUSINESSWIRE
Checkmate Pharmaceuticals prices IPO at $15 midpoint
07 Aug 2020 //
NASDAQ
Checkmate Granted FDA Fast Track for CMP-001 Combined with PD-1 Blockade
27 Jul 2020 //
BIOSPACE
Checkmate Pharmaceuticals Granted FDA Fast Track Designation for CMP-001
27 Jul 2020 //
BUSINESSWIRE
IPO bound? Five years in, Art Krieg and the Checkmate crew collect $85M
10 Jun 2020 //
ENDPTS
Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
09 Jun 2020 //
BUSINESSWIRE
Aeglea, long-term Eli Lilly veteran nabs CMO job at Checkmate
15 Oct 2019 //
FIERCE BIOTECH
